Abstract
ABSTRACT.As the COVD-19 pandemic spreads, several new severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) variants with various mutations across the genome have arisen, and they appear to be the greater risk to global public health. In this study, we have performed molecular characterization of SARS-COV-2 circulating in India between January 2020 and May 2021. Phylogenetic analysis of the SARS-COV-2 reported in the first and second waves of the outbreak showed the evolutionary hierarchy of SARS-COV-2 that was dispersed across the evolutionary tree of SARS-COV-2 with six major next strain clades: 19A (5.3%), 20A (29.9%), 20B (24.9%), 20I-Alpha, V1 (7.4%), 21A-Delta (17.2%), and 21B-Kappa (12.7%). Among the observed clades, 21A-Delta and 21B-Kappa belonging to the B.1.617 and its sublineages are the two notable clades that dominated approximately 78% of the total SARS-COV-2 genomes reported during April and May 2021. This study has also established a link between different SARS-COV-2 variants and risk of mortality during the COVID-19 epidemic using multivariable logistic regression model for patient-level data. The estimated model demonstrates that the risk of mortality of the COVID 19 patients infected by variant B.1.617 and/or its sublineages is much higher than the other preexisting SARS-COV-2 variants, especially among individuals over 45 years of age, regardless of gender. Considering the transmissibility of the B.1.617 and its sublineages and its potential impact to the public health, real-time analysis of COVID-19 cases coupled with stringent genomics surveillance are promising tools to develop and adapt stringent measures to contain and reduce the impact of SARS-COV-2.
Highlights
COVID-19 is an emerging infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARSCOV-2) that has posed an unprecedented challenge to public health
The second wave of COVID-19 in India, which started in January 2021, was characterized by the emergence and/or circulation of a new variant named B.1.617.8,14 This newly emerged variant was characterized by having common signature mutations—D111D, G142D, L452R, E484Q, D614G, and P681R—in the spike protein, including within the receptor-binding domain (RBD).[14]
The significant mutational landscape of Indian SARS-COV-2 follows the global trends where D614G was found to be more prevalent in the global pandemic and associated with mutations in nonstructural protein 3 (NSP3), RNA-dependent RNA polymerase (RdRp), and 5' UTR region.[19]
Summary
COVID-19 is an emerging infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARSCOV-2) that has posed an unprecedented challenge to public health. Laboratory investigations have established the higher infectivity and increased pathological changes associated with the infection of newly emerged
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American journal of tropical medicine and hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
